Donor Selection And Cell Source Summit The Clift Royal Sonesta San Francisco, San Francisco

As the allogeneic cell therapy space continues to mature with over 150+ clinical trials currently underway, and landmark milestones achieved with the first FDA approvals for allogeneic cell products – all eyes are turning to the backbones of these cell therapies – the cell donors. The field is awakening to the challenging reality of the increased demand for donor material to meet the required dosing needs for later stage clinical trials and licensed products.

Enter the timely arrival of the inaugural Donor Selection and Cell Source Summit, the pioneering forum for cell therapy leaders within process development, supply chain, procurement, R and D and analytics, placing a spotlight focus on cell source starting material for the first time.

With experts showcasing in-depth case studies of novel technology platforms and cell sources being utilized to increase yield, and new donor characteristic screening strategies to select for ‘gold-standard’ donors to achieve optimal clinical results for patients.

Speakers: Aaron Goldman – Instructor in Medicine | Director of Drug Resistance – Brigham and Women’s Hospital, Allen Feng – Founder | CSO – HebeCell, Amanda Conerty – Exec. Director Process, Analytical Development and Manufacturing – Artiva Biotherapeutics and More.

⌛ Event Dates & Venue

28 Nov - 30 Nov 2023, 9:00 am - 3:30 pm

💸 Website & Tickets

Go to Event Website
Ticket Pricing:
Full Conference Access - Drug Developer: USD 4297.00, Conference + 1 Workshop - Drug Developer: USD 3648.00, Conference Only - Drug Developer: USD 2999.00, Full Conference Access - Academic and Research Institute: USD 3697.00, Conference + 1 Workshop - Academic and Research Institute: USD 3148.00, Conference Only - Academic and Research Institute: USD 2599.00, Full Conference Access - Service Provider: USD 5297.00, Conference + 1 Workshop - Service Provider: USD 4548.00, Conference Only - Service Provider: USD 3799.00